Across TCGA pan-cancer cohorts, ZNF252P Mutation is linked to patient survival in 3 of 34 cancer types, making it a survival-associated ZNF252P data layer compared with 20 for mass-spec protein.
The strongest signal is observed in thymoma (THYM), where higher ZNF252P Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ZNF252P expression acts as an unfavorable survival marker.
THYM, READ, and UCEC are the cancer types where ZNF252P Mutation most reproducibly stratifies survival.
Mutation survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.